Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Ovarian Carcinosarcoma × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 22 Uterine Cervical Neoplasms 10 Fallopian Tube Neoplasms 10 Endometrial Neoplasms 10 Carcinoma, Ovarian Epithelial 7 Colorectal Neoplasms 5 Uterine Cervical Dysplasia 4 Peritoneal Neoplasms 4 Neoplasms 4 Gestational Trophoblastic Disease 4 Hematologic Neoplasms 3 Endometrial Hyperplasia 3 Thyroid Carcinoma, Anaplastic 2 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Progesterone Resistance 2 Pancreatic Neoplasms 2 Ovarian Cysts 2 Obesity 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Multiple Myeloma 2 Lung Neoplasms 2 Laryngeal Neoplasms 2 Glioma 2 Erdheim-Chester Disease 2 Cystadenocarcinoma, Serous 2 Carcinoma, Non-Small-Cell Lung 2 Vomiting 1 Uterine Neoplasms 1

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03651206 2025-12-19

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡